Therapeutic polymeric nanoparticles with mTor inhibitors and methods of making and using same
US8613951B2 · kind B2 · utility
136Cited by
27References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 16, 2009 |
| Grant date | Dec 24, 2013 |
| Priority date | — |
| Expiry date | Feb 18, 2031 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S977/773
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure generally relates to therapeutic nanoparticles. Exemplary nanoparticles disclosed herein may include about 1 to about 20 weight percent of a mTOR inhibitor; and about 70 to about 99 weight percent biocompatible polymer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.